Cargando…
Application of Pharmacokinetic-Pharmacodynamic Modeling to Inform Translation of In Vitro NaV1.7 Inhibition to In Vivo Pharmacological Response in Non-human Primate
PURPOSE: This work describes a staged approach to the application of pharmacokinetic-pharmacodynamic (PK-PD) modeling in the voltage-gated sodium ion channel (NaV1.7) inhibitor drug discovery effort to address strategic questions regarding in vitro to in vivo translation of target modulation. METHOD...
Autores principales: | Ballard, Jeanine E., Pall, Parul, Vardigan, Joshua, Zhao, Fuqiang, Holahan, Marie A., Kraus, Richard, Li, Yuxing, Henze, Darrell, Houghton, Andrea, Burgey, Christopher S., Gibson, Christopher |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7473964/ https://www.ncbi.nlm.nih.gov/pubmed/32888082 http://dx.doi.org/10.1007/s11095-020-02914-9 |
Ejemplares similares
-
Translational Pharmacokinetic–Pharmacodynamic Modeling of NaV1.7 Inhibitor MK-2075 to Inform Human Efficacious Dose
por: Ballard, Jeanine E., et al.
Publicado: (2021) -
Pharmacological validation of a novel nonhuman primate measure of thermal responsivity with utility for predicting analgesic effects
por: Vardigan, Joshua D, et al.
Publicado: (2018) -
Association of respiratory failure with inhibition of NaV1.6 in the phrenic nerve
por: Klein, Rebecca M., et al.
Publicado: (2022) -
Pharmacokinetics and pharmacodynamics of the novel Nrf2 activator omaveloxolone in primates
por: Reisman, Scott A, et al.
Publicado: (2019) -
Pharmacokinetics and pharmacodynamics of pozelimab alone or in combination with cemdisiran in non-human primates
por: Devalaraja-Narashimha, Kishor, et al.
Publicado: (2022)